| 0 |
LYSOSOMAL STORAGE DISORDER |
1 |
0.0526 |
| 1 |
NEAR DROWNING |
1 |
0.0057 |
| 2 |
FAECAL VOLUME INCREASED |
1 |
0.0019 |
| 3 |
POST-ACUTE COVID-19 SYNDROME |
2 |
0.0016 |
| 4 |
MAMMOPLASTY |
1 |
0.0013 |
| 5 |
CORONAVIRUS TEST POSITIVE |
1 |
0.0010 |
| 6 |
BLOOD TESTOSTERONE ABNORMAL |
1 |
0.0009 |
| 7 |
PALMAR ERYTHEMA |
1 |
0.0009 |
| 8 |
DRUG SPECIFIC ANTIBODY |
1 |
0.0007 |
| 9 |
TRACHEOSTOMY |
1 |
0.0007 |
| 10 |
INTESTINAL POLYP |
1 |
0.0006 |
| 11 |
EMPYEMA |
1 |
0.0005 |
| 12 |
SPUTUM INCREASED |
1 |
0.0005 |
| 13 |
PULMONARY FUNCTION TEST DECREASED |
2 |
0.0005 |
| 14 |
RASH VESICULAR |
2 |
0.0004 |
| 15 |
SLOW SPEECH |
1 |
0.0004 |
| 16 |
DENTAL OPERATION |
1 |
0.0004 |
| 17 |
MOTOR DYSFUNCTION |
4 |
0.0004 |
| 18 |
MIGRAINE WITH AURA |
1 |
0.0004 |
| 19 |
PROCTITIS |
1 |
0.0004 |
| 20 |
LUNG CANCER METASTATIC |
1 |
0.0003 |
| 21 |
HYPERCAPNIA |
1 |
0.0003 |
| 22 |
MASTICATION DISORDER |
1 |
0.0003 |
| 23 |
REHABILITATION THERAPY |
1 |
0.0003 |
| 24 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 25 |
DIVERTICULUM INTESTINAL |
1 |
0.0002 |
| 26 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0002 |
| 27 |
AFFECT LABILITY |
2 |
0.0002 |
| 28 |
CARDIAC FLUTTER |
1 |
0.0002 |
| 29 |
DRUG SPECIFIC ANTIBODY PRESENT |
1 |
0.0002 |
| 30 |
TERMINAL STATE |
1 |
0.0001 |
| 31 |
PRODUCT AVAILABILITY ISSUE |
3 |
0.0001 |
| 32 |
PRODUCT USE COMPLAINT |
2 |
0.0001 |
| 33 |
SENSATION OF FOREIGN BODY |
1 |
0.0001 |
| 34 |
GASTRITIS |
3 |
0.0001 |
| 35 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 36 |
INTENTIONAL DOSE OMISSION |
3 |
0.0001 |
| 37 |
HYPERSOMNIA |
3 |
0.0001 |
| 38 |
SUDDEN DEATH |
1 |
0.0001 |
| 39 |
DYSARTHRIA |
3 |
0.0001 |
| 40 |
INFUSION RELATED REACTION |
5 |
0.0001 |
| 41 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 42 |
HUNGER |
1 |
0.0001 |
| 43 |
LYMPHOPENIA |
1 |
0.0001 |
| 44 |
APATHY |
1 |
0.0001 |
| 45 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 46 |
COLON CANCER |
1 |
0.0001 |
| 47 |
INSURANCE ISSUE |
1 |
0.0001 |
| 48 |
BRAIN FOG |
1 |
0.0001 |
| 49 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 50 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 51 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 52 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 53 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 54 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
0.0000 |
| 55 |
THERAPY INTERRUPTED |
3 |
0.0000 |
| 56 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 57 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 58 |
MUSCULAR WEAKNESS |
4 |
0.0000 |
| 59 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 60 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 61 |
APHASIA |
1 |
0.0000 |
| 62 |
DISCOMFORT |
2 |
0.0000 |
| 63 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 64 |
HEART RATE DECREASED |
1 |
0.0000 |
| 65 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 66 |
COLITIS |
1 |
0.0000 |
| 67 |
GENERAL PHYSICAL HEALTH DETERIORATION |
3 |
0.0000 |
| 68 |
OEDEMA PERIPHERAL |
3 |
0.0000 |
| 69 |
POLLAKIURIA |
1 |
0.0000 |
| 70 |
ABDOMINAL DISCOMFORT |
4 |
0.0000 |
| 71 |
PRODUCT DOSE OMISSION ISSUE |
7 |
0.0000 |
| 72 |
HYPERTENSION |
5 |
0.0000 |
| 73 |
TACHYCARDIA |
2 |
0.0000 |
| 74 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 75 |
TINNITUS |
1 |
0.0000 |
| 76 |
HYPOKALAEMIA |
1 |
0.0000 |
| 77 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 78 |
DYSPHAGIA |
2 |
0.0000 |
| 79 |
MIGRAINE |
2 |
0.0000 |
| 80 |
DYSPEPSIA |
2 |
0.0000 |
| 81 |
ABDOMINAL PAIN UPPER |
4 |
0.0000 |
| 82 |
INFLAMMATION |
1 |
0.0000 |
| 83 |
NERVOUSNESS |
1 |
0.0000 |
| 84 |
ASTHENIA |
7 |
0.0000 |
| 85 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 86 |
TREMOR |
3 |
0.0000 |
| 87 |
NECK PAIN |
1 |
0.0000 |
| 88 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 89 |
MYALGIA |
3 |
0.0000 |
| 90 |
CHILLS |
2 |
0.0000 |
| 91 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 92 |
VERTIGO |
1 |
0.0000 |
| 93 |
PNEUMONIA |
5 |
0.0000 |
| 94 |
SOMNOLENCE |
3 |
0.0000 |
| 95 |
VOMITING |
7 |
0.0000 |
| 96 |
WEIGHT DECREASED |
4 |
0.0000 |
| 97 |
MOBILITY DECREASED |
1 |
0.0000 |
| 98 |
MALAISE |
6 |
0.0000 |
| 99 |
DYSGEUSIA |
1 |
0.0000 |
| 100 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 101 |
FATIGUE |
10 |
0.0000 |
| 102 |
NAUSEA |
10 |
0.0000 |
| 103 |
FEELING ABNORMAL |
3 |
0.0000 |
| 104 |
CARDIAC FAILURE |
1 |
0.0000 |
| 105 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 106 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 107 |
URTICARIA |
2 |
0.0000 |
| 108 |
BALANCE DISORDER |
1 |
0.0000 |
| 109 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 110 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 111 |
PRURITUS |
4 |
0.0000 |
| 112 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 113 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 114 |
HEART RATE INCREASED |
1 |
0.0000 |
| 115 |
HYPOTENSION |
2 |
0.0000 |
| 116 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 117 |
ERYTHEMA |
2 |
0.0000 |
| 118 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 119 |
FALL |
3 |
0.0000 |
| 120 |
DYSPNOEA |
5 |
0.0000 |
| 121 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 122 |
DECREASED APPETITE |
2 |
0.0000 |
| 123 |
BACK PAIN |
2 |
0.0000 |
| 124 |
DIZZINESS |
4 |
0.0000 |
| 125 |
HEADACHE |
5 |
0.0000 |
| 126 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 127 |
HYPERHIDROSIS |
1 |
0.0000 |
| 128 |
DEHYDRATION |
1 |
0.0000 |
| 129 |
ANXIETY |
2 |
0.0000 |
| 130 |
RASH |
3 |
0.0000 |
| 131 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 132 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 133 |
PARAESTHESIA |
1 |
0.0000 |
| 134 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 135 |
DEATH |
5 |
0.0000 |
| 136 |
COVID-19 |
1 |
0.0000 |
| 137 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 138 |
CHEST PAIN |
1 |
0.0000 |
| 139 |
PAIN |
3 |
0.0000 |
| 140 |
OFF LABEL USE |
4 |
0.0000 |
| 141 |
WEIGHT INCREASED |
1 |
0.0000 |
| 142 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 143 |
INSOMNIA |
1 |
0.0000 |
| 144 |
COUGH |
1 |
0.0000 |
| 145 |
DIARRHOEA |
2 |
0.0000 |
| 146 |
PYREXIA |
1 |
0.0000 |